BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14657952)

  • 41. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
    Jung M; Lee C; Park JH; Moon KC
    Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.
    Renshaw AA; Granter SR; Fletcher JA; Kozakewich HP; Corless CL; Perez-Atayde AR
    Am J Surg Pathol; 1999 Jul; 23(7):795-802. PubMed ID: 10403302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant Expression of E-cadherin, N-cadherin, and P-cadherin in Clear Cell Renal Cell Carcinoma: Association With Adverse Clinicopathologic Factors and Poor Prognosis.
    Jang NR; Choi JH; Gu MJ
    Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):223-230. PubMed ID: 32341236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.
    Shen SS; Krishna B; Chirala R; Amato RJ; Truong LD
    Mod Pathol; 2005 Jul; 18(7):933-40. PubMed ID: 15696118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
    Perret AG; Clemencon A; Li G; Tostain J; Peoc'h M
    BJU Int; 2008 Jul; 102(2):183-7. PubMed ID: 18422770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
    Ahmed EA; Youssif ME
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R
    Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
    Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
    Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
    Mete O; Kilicaslan I; Gulluoglu MG; Uysal V
    Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
    Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD10 is a diagnostic and prognostic marker in renal malignancies.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    Histopathology; 2004 Nov; 45(5):460-7. PubMed ID: 15500649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma.
    Gasinska A; Jaszczynski J; Adamczyk A; Janecka-Widła A; Wilk W; Cichocka A; Stelmach A
    Folia Histochem Cytobiol; 2018; 56(4):195-206. PubMed ID: 30569446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
    Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
    Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.
    Shimazui T; Kojima T; Onozawa M; Suzuki M; Asano T; Akaza H
    Oncol Rep; 2006 May; 15(5):1181-4. PubMed ID: 16596183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.